Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study has suggested.

Ozempic, Wegovy and Mounjaro can reduce risk of heart disease, dementia, and much more, says groundbreaking US study ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

Researchers from the Washington University School of Medicine looked at the health outcomes among more than two million people taking the popular weight-loss medications.

Elon Musk has shared his weight loss journey, revealing how he transformed his health with the help of medication, intermittent fasting, and lifestyle changes.

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

Does the natural Mounjaro drink really help with weight loss like the FDA-approved medication? Experts weigh in on the claims ...